SARS-CoV-2-IN-46
196.83 €
In Stock
quantity
product details
Catalog number: 804 - HY-155016
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 10 mg
HY-155016
SARS-CoV-2-IN-46
SARS-CoV-2-IN-46 is a novel coronavirus (SARS-CoV-2) replication inhibitor with an EC50 of 0.9 μM in Calu-3 cells. SARS-CoV-2-IN-46 has antiviral activity and can be used in novel coronavirus (COVID-19) research[1].
196.83 €
HY-135856
SARS-CoV-IN-2
SARS-CoV-IN-2 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-2 shows anti-Coronavirus activity with an EC50 of 1.9 μM in Vero cells. SARS-CoV-IN-2 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 21.5 and 30 nM; and IC90s of 51.0 and 99.9 nM; respectively. SARS-CoV-IN-2 reduces HIV-1-induced cytopathic effect with an EC50 of 2.9 μM in MT-4 cells. Antimalarial and Antiviral Activities[1].
3738.43 €
HY-154975
SARS-CoV-2-IN-49
SARS-CoV-2-IN-49 is an irreversible covalent inhibitor of SARS-CoV-2 main protease[1].
Ask for quotation
HY-154976
SARS-CoV-2-IN-50
SARS-CoV-2-IN-50 (Compound X77C) is a SARS-CoV-2 main protease (MPro) inhibitor.. SARS-CoV-2-IN-50 has a high affinity to the catalytic site of MPro[1].